30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
In today’s edition of Daily Compliance News: • House report blasts both Boeing and FAA. (NYT) • G...
Read More >
Our autumn round-up of articles written by colleagues highlights a wide range of issues affecting bu...
Read More >
Amazon announced this week that it will spend $700 million to retrain a third of its US workforce to...
Read More >
This article focuses on 401(k) and 403(b) plans that are in one of the following situations: 1. The...
Read More >
Courtyard Monroe Airport Hotel Paid Women Less Because of Their Gender, Federal Agency Charges - NE...
Read More >
A majority of dealmakers say their companies are focused on defense or survival, but about a quarter...
Read More >